BREAST CANCER PANEL 2

ER & PR receptor assays are routinely performed on Breast carcinomas to assess responsiveness to endocrine therapy and prognosis. Cathepsin D positivity is a poor prognostic sign.

  • Test Type:
  • Pre-test Information:
    Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
  • Report Delivery:
    Sample Daily by 6 pm; Report Block : 5 days Tissue biopsy : 5 days Tissue large complex : 7 days
  • Components:
    0

Sample Report